Ioannis Fotopoulos

Dr. Ioannis Fotopoulos

Laboratoire CARMeN, Université de Rouen Normandie, Rouen, Normandie, France
orcid
Post-doctoral Reseacher at Université de Rouen

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2020 in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Ioannis FotopoulosIoannis Fotopoulos
Ioannis Fotopoulos
DHDimitra Hadjipavlou-Litina
Dimitra Hadjipavlou-Litina
Background: Coumarins exhibit a plethora of biological activities, e.g. antiinflammatory and anti-tumor. Molecular hybridization technique has been implemented in the design of novel coumarin hybrids with several bioactive groups in order to obtain molecules with better pharmacological activity and improved pharmacokinetic profile.Objective: Therefore, we tried to gather as many as possible biologically active coumarin hybrids referred in the literature till now, to delineate the structural characteristics in relation to the activities and to have a survey that might help the medicinal chemists to design new coumarin hybrids with drug-likeness and varied bioactivities.Results: The biological activities of the hybrids in most of the cases were found to be different from the biological activities presented by the parent coumarins. The results showed that the hybrid molecules are more potent compared to the standard drugs used in the evaluation experiments.Conclusion: Conjugation of coumarin with varied pharmacophore groups/druglike molecules responsible for different biological activities led to many novel hybrid molecules, with a multitarget behavior and improved pharmacokinetic properties.

8 January 2019 in Current Pharmaceutical Biotechnology
Verified
Journal Article
Closed access
PDF file
EPEleni Pontiki
Eleni Pontiki
APAikaterini Peperidou
Aikaterini Peperidou
Ioannis FotopoulosIoannis Fotopoulos
Ioannis Fotopoulos
DHDimitra Hadjipavlou-Litina
Dimitra Hadjipavlou-Litina
Cinnamic acid derivatives are widely distributed in nature presenting a wide range of biological activities: antiseptic, stimulant, carminative and insecticide activities. Hydroxy cinnamic acids especially caffeic, ferulic chlorogenic present various biological activities and they are synthesized in nature through the phenyl propanoid pathway. The cinnamic moiety is still present in various drugs such as a) Ozagrel, an imidazole π-substituted cinnamic acid acting as a thromboxane A2 synthase inhibitor, used therapeutically for treating acute ischemic stroke, b) Cinnarizine, Cinanserin, Tranilasta series of antiallergic agents etc. During the last decade scientists have focused on multifunctional molecules instead of a single molecule hitting one target. Multi-target drugs can be beneficial for the treatment of complex and multifunctional diseases.A variety of multi-target drugs contain the cinnamic acid moiety due to its biological importance and combination of biological activities e.g. antioxidant, antiiflammatory, anticancer, antituberculosis, antifungal, antimalarial, antiatherogenic, antimicrobial activities. Recently for the treatment of complex diseases hybrid drugs combining two pharmaceutical moieties in one molecule have been developed. These molecules are more medically effective than their individual components. In this review is given a survey of cinnamate hybrids, molecules that combine the cinnamic acid moiety with a second at least pharmacophore with or without a linker, acting as “multi-target” agents. The hybrids are listed in terms of their biological activity and applications as anti-Alzheimer, anticancer agents as well as for cardiovascular diseases, as antivirals, antimalarials etc.

6 August 2024 in Expert Opinion on Drug Discovery
Verified
Journal Article
Closed access
Ioannis FotopoulosIoannis Fotopoulos
Ioannis Fotopoulos
DHDimitra Hadjipavlou-Litina
Dimitra Hadjipavlou-Litina
Cinnamic acid is a privileged scaffold for the design of biologically active compounds with putative anticancer potential, following different synthetic methodologies and procedures. Since there is a need for the production of potent anticancer, cinnamate moiety can significantly contribute in the design of new and more active anticancer agents. In this review, the authors provide a review on the synthetic approaches for the discovery of cinnamic acid derivatives with anticancer potential. Results from molecular simulations, hybridization, and chemical derivatization along with biological experiments in vitro and structural activity relationships are given, described, and discussed by the authors. Information for the mechanism of action is taken from original literature sources. The authors suggest that (i) numerous areas of biology-pharmacology need to be considered: selectivity, in vivo studies, toxicity and drug-likeness, the mechanism of action in animals and humans, development of more efficient assays for various cancer types; (ii) hybridization techniques outbalance in the discovery and production of compounds with higher activity and greater selectivity; (iii) repositioning offers new anticancer cinnamic agents.

18 January 2023 in Molecules
Verified
Journal Article
Open access
PDF file
ANAlexandros Nakas
Alexandros Nakas
GGGeorgia Giannarelli
Georgia Giannarelli
Ioannis FotopoulosIoannis Fotopoulos
Ioannis Fotopoulos
ECEIRINI CHAINOGLOU
EIRINI CHAINOGLOU
KPKaterina Peperidou
Katerina Peperidou
AAAndreana N. Assimopoulou
Andreana N. Assimopoulou
The aim of the present work was to optimize the conditions of the distillation process at a pilot scale to maximize the yield of specific bioactive compounds of the essential oil of oregano cultivated in Greece, and subsequently to study the in vitro antioxidant activity of these oils. Steam distillation was conducted at an industrial distillery and a Face-Centered Composite (FCC) experimental design was applied by utilizing three distillation factors: time, steam pressure and temperature. Essential oil composition was determined by static headspace gas chromatography–mass spectrometry (HS–GC/MS). To obtain a comprehensive profile of the essential oils, instrumental parameters were optimized, including sample preparation, incubation conditions, sampling process, injection parameters, column thermal gradient and MS conditions. With the applied GC-MS method, more than 20 volatile compounds were identified in the headspace of the oregano essential oils and their relative percentages were recorded. Carvacrol was the most prominent constituent under all distillation conditions applied. Data processing revealed time as the main factor which most affected the yield. The Desired Space (DSc) was determined by conducting a three-dimensional response surface analysis of the independent and dependent variables, choosing yields of thymol and carvacrol as optimization criteria. The in vitro antioxidant activity of the essential oils of all samples was measured in terms of the interaction with the stable free radical 2,2-diphenyl-1-picrylhydrazyl (DPPH) after 20 and 60 min. The most prominent essential oils at different distillation conditions were also tested as inhibitors of lipid peroxidation. Higher % values of carvacrol and thymol were correlated to higher antioxidant activity. Evaluating the impact of the distillation conditions on the in vitro results, it seems that lower pressure, less time and higher temperature are crucial for enhanced antioxidant activities.

27 May 2022 in European Journal of Medicinal Chemistry Reports
Verified
Journal Article
Open access
EVEvangelia-Eirini N. Vlachou
Evangelia-Eirini N. Vlachou
Ioannis FotopoulosIoannis Fotopoulos
Ioannis Fotopoulos
CGCatherine Gabriel
Catherine Gabriel
EPEleni Pontiki
Eleni Pontiki
DHDimitra J. Hadjipavlou-Litina
Dimitra J. Hadjipavlou-Litina
LKLitinas Konstantinos
Litinas Konstantinos

31 December 2019 in Letters in Drug Design & Discovery
Verified
Journal Article
Closed access
PDF file
Ioannis FotopoulosIoannis Fotopoulos
Ioannis Fotopoulos
EPEleni Pontiki
Eleni Pontiki
DLDimitra Hadjipavlou Litina
Dimitra Hadjipavlou Litina
Background: Cinnamic acid is a key intermediate in shikimate and phenylpropanoid pathways. It is found both in free form, and especially in the form of esters in various essential oils, resins and balsams which are very important intermediates in the biosynthetic pathway of several natural products. The cinnamic derivatives play a vital role in the formation of commercially important intermediate molecules which are necessary for the production of different bioactive compounds and drugs. Different substitutions on basic moiety lead to various biological activities. Furthermore, combination of appropriate pharmacophore groups with cinnamic acid derivatives were developed to give hybrids in order to find out promising drug candidates as inhibitors of multiple biological targets associated with inflammation. We found interesting to continue our efforts to design and synthesise three series of novel cinnamic acid-based hybrids: a) nitrooxy esters of cinnamic acid, b) ethers and c) amides of cinnamic acids with arginine, as pleiotropic candidates against multiple targets of inflammation.Methods: The synthesis of cinnamic was established by a Knoevenagel-Doebner condensation of the suitable aldehyde either with malonic acid in the presence of pyridine and piperidine, or with phenylacetic acid in the precence of triethylamine in acetic anhydride. The synthesis of the corresponding esters was conducted in two steps. The ethers were synthesized in low yields, with 1,2 – dibromoethane in dry acetone, in the presence of K2CO3, to give oily products. The corresponding cinnamic amides were synthesised in a single step. The synthesised hybrids were tested as lipoxygenase (LOX) and cyclooxygenase (COX) inhibitors in vitro. In silico docking was applied to all the novel derivatives. Several molecular properties of the hybrids were calculated in order to evaluate their drug likeness.Results: A number of esters, ethers and amides of selected cinnamic acids, either phenyl substituted or not, has been synthesised and subjected to modelling studies. The compounds were studied in vitro/in vivo for their inhibitory activities on cox and lox, and as antioxidants. Log P values of all the title compounds except of 3a (5.38) were found to be less than 5 and are in agreement to Lipinski’s rule of five, suggesting satisfactory permeability across cell membrane. The molecular modelling study seems to be in accordance with the experimental results for LOX and COX-2. The result of antioxidant activity for amide 3b supports the anti-lox activity. Compound 5d presents the higher in vivo anti-inflammatory.Conclusion: According to the experimental findings compounds 3b and 5d can be used as lead compounds for the design of new molecules to target inflammation.